Logo for Graphite Bio Inc

Graphite Bio Investor Relations Material

Latest events

Logo for Graphite Bio Inc

M&A Announcement

Graphite Bio
Logo for Graphite Bio

M&A Announcement

15 Nov, 2023
Logo for Graphite Bio

Q3 2023

13 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for diseases, primarily focused on therapies for serious and life-threatening diseases, in the United States. The company develops TALEN gene editing system for the treatment of various human diseases, including cancers. It is also involved in developing electroporation technology for drug and gene delivery.